Identification of the HABP2 rs7080536 common variant as candidate for FNMTC was based largely on differences in allele frequencies across populations, familial segregation within a single pedigree, and mechanistic biological support. This evidence concerns the gene HABP2 and familial papillary or follicular thyroid carcinoma.